Olujić, D.

Link to this page

Authority KeyName Variants
e300b1a6-135c-444e-9943-096fc1fb6be8
  • Olujić, D. (1)
Projects

Author's Bibliography

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

De Backer, G.; Jankowski, P.; Dilić, M.; Lalić, N.; Lović, D.; Miličić, D.; Vulić, D.; Begić, A.; Durak Nalbantić, A.; Hadzibegić, N.; Kapidjić, S.; Resić, N.; Sabanović Bajramović, N.; Zvizdić, F.; Kovacević-Preradović, T.; Popović-Pejicić, S.; Đekić, D.; Gnjatić, T.; Knezević, T.; Stanetić, B.; Topić, G.; Milicić, D.; Bosnić, A.; Dubravcić, M.; Pavasović, S.; Samardžić, Jelena; Batinić, T.; Delić-Brkljacić, D.; Golubić, K.; Kordić, K.; Nedić, M.; Olujić, D.; Sedinić, V.; Blazević, T.; Pasalić, A.; Percić, M.; Sikić, J.; Aleksić, M.; Đokić, Jelena; Hinić, S.; Zdravković, M.; Lalić, N.M.; Jotić, A.; Lalić, K.; Lukić, L.; Milicić, T.; Macesić, M.; Stanarcić Gajović, J.; Stoiljković, M.; Đorđević, D.; Kostić, S.; Tasić, I.; Vuković, A.; Kugonjič, U.; (broj koatora 519)

(Elsevier Ireland Ltd, 2019)

TY  - JOUR
AU  - De Backer, G.
AU  - Jankowski, P.
AU  - Dilić, M.
AU  - Lalić, N.
AU  - Lović, D.
AU  - Miličić, D.
AU  - Vulić, D.
AU  - Begić, A.
AU  - Durak Nalbantić, A.
AU  - Hadzibegić, N.
AU  - Kapidjić, S.
AU  - Resić, N.
AU  - Sabanović Bajramović, N.
AU  - Zvizdić, F.
AU  - Kovacević-Preradović, T.
AU  - Popović-Pejicić, S.
AU  - Đekić, D.
AU  - Gnjatić, T.
AU  - Knezević, T.
AU  - Stanetić, B.
AU  - Topić, G.
AU  - Milicić, D.
AU  - Bosnić, A.
AU  - Dubravcić, M.
AU  - Pavasović, S.
AU  - Samardžić, Jelena
AU  - Batinić, T.
AU  - Delić-Brkljacić, D.
AU  - Golubić, K.
AU  - Kordić, K.
AU  - Nedić, M.
AU  - Olujić, D.
AU  - Sedinić, V.
AU  - Blazević, T.
AU  - Pasalić, A.
AU  - Percić, M.
AU  - Sikić, J.
AU  - Aleksić, M.
AU  - Đokić, Jelena
AU  - Hinić, S.
AU  - Zdravković, M.
AU  - Lalić, N.M.
AU  - Jotić, A.
AU  - Lalić, K.
AU  - Lukić, L.
AU  - Milicić, T.
AU  - Macesić, M.
AU  - Stanarcić Gajović, J.
AU  - Stoiljković, M.
AU  - Đorđević, D.
AU  - Kostić, S.
AU  - Tasić, I.
AU  - Vuković, A.
AU  - Kugonjič, U.
AU  - (broj koatora 519)
PY  - 2019
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1231
AB  - Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.
PB  - Elsevier Ireland Ltd
T2  - Atherosclerosis
T1  - Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
EP  - 146
SP  - 135
VL  - 285
DO  - 10.1016/j.atherosclerosis.2019.03.014
ER  - 
@article{
author = "De Backer, G. and Jankowski, P. and Dilić, M. and Lalić, N. and Lović, D. and Miličić, D. and Vulić, D. and Begić, A. and Durak Nalbantić, A. and Hadzibegić, N. and Kapidjić, S. and Resić, N. and Sabanović Bajramović, N. and Zvizdić, F. and Kovacević-Preradović, T. and Popović-Pejicić, S. and Đekić, D. and Gnjatić, T. and Knezević, T. and Stanetić, B. and Topić, G. and Milicić, D. and Bosnić, A. and Dubravcić, M. and Pavasović, S. and Samardžić, Jelena and Batinić, T. and Delić-Brkljacić, D. and Golubić, K. and Kordić, K. and Nedić, M. and Olujić, D. and Sedinić, V. and Blazević, T. and Pasalić, A. and Percić, M. and Sikić, J. and Aleksić, M. and Đokić, Jelena and Hinić, S. and Zdravković, M. and Lalić, N.M. and Jotić, A. and Lalić, K. and Lukić, L. and Milicić, T. and Macesić, M. and Stanarcić Gajović, J. and Stoiljković, M. and Đorđević, D. and Kostić, S. and Tasić, I. and Vuković, A. and Kugonjič, U. and (broj koatora 519)",
year = "2019",
abstract = "Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. Methods: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C-lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. Results: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self-reported diabetes. Conclusions: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.",
publisher = "Elsevier Ireland Ltd",
journal = "Atherosclerosis",
title = "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries",
pages = "146-135",
volume = "285",
doi = "10.1016/j.atherosclerosis.2019.03.014"
}
De Backer, G., Jankowski, P., Dilić, M., Lalić, N., Lović, D., Miličić, D., Vulić, D., Begić, A., Durak Nalbantić, A., Hadzibegić, N., Kapidjić, S., Resić, N., Sabanović Bajramović, N., Zvizdić, F., Kovacević-Preradović, T., Popović-Pejicić, S., Đekić, D., Gnjatić, T., Knezević, T., Stanetić, B., Topić, G., Milicić, D., Bosnić, A., Dubravcić, M., Pavasović, S., Samardžić, J., Batinić, T., Delić-Brkljacić, D., Golubić, K., Kordić, K., Nedić, M., Olujić, D., Sedinić, V., Blazević, T., Pasalić, A., Percić, M., Sikić, J., Aleksić, M., Đokić, J., Hinić, S., Zdravković, M., Lalić, N.M., Jotić, A., Lalić, K., Lukić, L., Milicić, T., Macesić, M., Stanarcić Gajović, J., Stoiljković, M., Đorđević, D., Kostić, S., Tasić, I., Vuković, A., Kugonjič, U.,& (broj koatora 519). (2019). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. in Atherosclerosis
Elsevier Ireland Ltd., 285, 135-146.
https://doi.org/10.1016/j.atherosclerosis.2019.03.014
De Backer G, Jankowski P, Dilić M, Lalić N, Lović D, Miličić D, Vulić D, Begić A, Durak Nalbantić A, Hadzibegić N, Kapidjić S, Resić N, Sabanović Bajramović N, Zvizdić F, Kovacević-Preradović T, Popović-Pejicić S, Đekić D, Gnjatić T, Knezević T, Stanetić B, Topić G, Milicić D, Bosnić A, Dubravcić M, Pavasović S, Samardžić J, Batinić T, Delić-Brkljacić D, Golubić K, Kordić K, Nedić M, Olujić D, Sedinić V, Blazević T, Pasalić A, Percić M, Sikić J, Aleksić M, Đokić J, Hinić S, Zdravković M, Lalić N, Jotić A, Lalić K, Lukić L, Milicić T, Macesić M, Stanarcić Gajović J, Stoiljković M, Đorđević D, Kostić S, Tasić I, Vuković A, Kugonjič U, (broj koatora 519). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. in Atherosclerosis. 2019;285:135-146.
doi:10.1016/j.atherosclerosis.2019.03.014 .
De Backer, G., Jankowski, P., Dilić, M., Lalić, N., Lović, D., Miličić, D., Vulić, D., Begić, A., Durak Nalbantić, A., Hadzibegić, N., Kapidjić, S., Resić, N., Sabanović Bajramović, N., Zvizdić, F., Kovacević-Preradović, T., Popović-Pejicić, S., Đekić, D., Gnjatić, T., Knezević, T., Stanetić, B., Topić, G., Milicić, D., Bosnić, A., Dubravcić, M., Pavasović, S., Samardžić, Jelena, Batinić, T., Delić-Brkljacić, D., Golubić, K., Kordić, K., Nedić, M., Olujić, D., Sedinić, V., Blazević, T., Pasalić, A., Percić, M., Sikić, J., Aleksić, M., Đokić, Jelena, Hinić, S., Zdravković, M., Lalić, N.M., Jotić, A., Lalić, K., Lukić, L., Milicić, T., Macesić, M., Stanarcić Gajović, J., Stoiljković, M., Đorđević, D., Kostić, S., Tasić, I., Vuković, A., Kugonjič, U., (broj koatora 519), "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries" in Atherosclerosis, 285 (2019):135-146,
https://doi.org/10.1016/j.atherosclerosis.2019.03.014 . .
41
234
220